This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Zywie Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Stephen Anderson and Ambroxol-Related Therapeutic Innovation
Introduction
Stephen Anderson is an inventor associated with Princeton, New Jersey, and Zywie Inc. His patent work concerns modified forms of ambroxol and their potential therapeutic applications.
Latest Patents
Anderson is credited with 1 patent: “Modified Forms of Ambroxol for Therapeutic Use.” The invention describes analog forms of ambroxol and related compounds, compositions containing them, and methods for preventing or treating diseases and medical conditions through their administration.
Career Highlights
Anderson’s listed patent reflects work at the intersection of chemical innovation and therapeutic development. The patent identifies Zywie Inc. as the company with which he is associated.
Collaborations
His listed coworkers include Stephen Pasternak and Vincent Jacques.
Conclusion
Stephen Anderson’s patent focuses on modified ambroxol compounds and their possible use in therapeutic compositions and treatment methods.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile